Date Filed | Type | Description |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2023 |
4
| Floyd Robert Michael (COO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns:
| Granted 10,851 restricted stock units
@ $0 Granted 55,107 restricted stock units
@ $0 Granted 40,690 restricted stock units
@ $0 |
|
10/11/2022 |
4
| Floyd Robert Michael (COO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns:
| Exercised 12,500 shares
@ $0 Paid exercise price by delivering 4,163 shares
@ $0 |
|
10/03/2022 |
4
| Floyd Robert Michael (COO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns:
| Granted 10,850 restricted stock units
@ $0 |
|
08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/11/2022 |
4
| Floyd Robert Michael (COO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns:
| Granted 247,841 restricted stock units
@ $0 |
|
04/04/2022 |
4
| Floyd Robert Michael (COO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns:
| Gifted 7,000 shares
@ $0 Granted 4,286 restricted stock units
@ $0 Granted 10,715 restricted stock units
@ $0 |
|
01/06/2022 |
4/A
| Floyd Robert Michael (COO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns:
| Granted 6,722 restricted stock units
@ $0 |
|
01/06/2022 |
4/A
| Floyd Robert Michael (COO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns:
| Granted 6,024 restricted stock units
@ $0 |
|
01/04/2022 |
4
| Floyd Robert Michael (COO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns:
| Granted 6,722 restricted stock units
@ $0 |
|
10/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/16/2020 |
3
| Floyd Robert Michael (COO) has filed a Form 3 on Processa Pharmaceuticals, Inc. |